207 related articles for article (PubMed ID: 2969083)
21. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.
Hutson PH; Dourish CT; Curzon G
Eur J Pharmacol; 1986 Oct; 129(3):347-52. PubMed ID: 2430815
[TBL] [Abstract][Full Text] [Related]
22. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
Andersen HL; Kilpatrick IC
Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
[TBL] [Abstract][Full Text] [Related]
23. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Tricklebank MD; Neill J; Kidd EJ; Fozard JR
Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat.
Wadenberg ML; Hillegaart V
Neuropharmacology; 1995 May; 34(5):495-9. PubMed ID: 7566483
[TBL] [Abstract][Full Text] [Related]
25. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
26. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
Gradin K; Pettersson A; Hedner T; Persson B
J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997
[TBL] [Abstract][Full Text] [Related]
27. Effect of chronic treatment with 8-OH-DPAT in the forced swimming test requires the integrity of presynaptic serotonergic mechanisms.
Cervo L; Samanin R
Psychopharmacology (Berl); 1991; 103(4):524-8. PubMed ID: 1829537
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats.
Connor HE; Higgins GA
Eur J Pharmacol; 1990 Jun; 182(1):63-72. PubMed ID: 2144824
[TBL] [Abstract][Full Text] [Related]
29. Serotonergic involvement in haloperidol-induced catalepsy.
Neal-Beliveau BS; Joyce JN; Lucki I
J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
[TBL] [Abstract][Full Text] [Related]
30. Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats.
Gerber R; Altar CA; Liebman JM
Psychopharmacology (Berl); 1988; 94(2):178-82. PubMed ID: 2965396
[TBL] [Abstract][Full Text] [Related]
31. Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat.
Hillegaart V; Hjorth S; Ahlenius S
J Neural Transm Gen Sect; 1990; 81(2):131-45. PubMed ID: 2141990
[TBL] [Abstract][Full Text] [Related]
32. 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task.
Carli M; Tranchina S; Samanin R
Eur J Pharmacol; 1992 Feb; 211(2):227-34. PubMed ID: 1535320
[TBL] [Abstract][Full Text] [Related]
33. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.
Bill DJ; Knight M; Forster EA; Fletcher A
Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
[TBL] [Abstract][Full Text] [Related]
35. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
36. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens.
Ohno Y; Shimizu S; Imaki J; Ishihara S; Sofue N; Sasa M; Kawai Y
Neuropharmacology; 2008 Oct; 55(5):717-23. PubMed ID: 18585397
[TBL] [Abstract][Full Text] [Related]
37. 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance.
Dourish CT; Hutson PH; Kennett GA; Curzon G
Appetite; 1986; 7 Suppl():127-40. PubMed ID: 2943219
[TBL] [Abstract][Full Text] [Related]
38. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis.
Hutson PH; Sarna GS; O'Connell MT; Curzon G
Neurosci Lett; 1989 May; 100(1-3):276-80. PubMed ID: 2474776
[TBL] [Abstract][Full Text] [Related]
39. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
Tricklebank MD; Forler C; Fozard JR
Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568
[TBL] [Abstract][Full Text] [Related]
40. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat.
Hillegaart V
Physiol Behav; 1990 Jul; 48(1):143-8. PubMed ID: 2146690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
